Revisiting the criteria for exchange transfusion for severe neonatal hyperbilirubinemia in resource-limited settings

Neonatology

Volumn 109, Issue 2, 2016, Pages 97-104

  Olusanya, Bolajoko O ^a   Imam, Zainab O ^b   Emokpae, Abieyuwa A ^b   Iskander, Iman F ^c  

^a Healthy Start Initiative   (Nigeria)

^b Massey Street Children Hospital   (Nigeria)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Bilirubin encephalopathy; Developing countries; Hemolysis; Kernicterus; Neurotoxicity

Indexed keywords

BILIRUBIN;

BILIRUBIN BLOOD LEVEL; CLINICAL EVALUATION; EXCHANGE BLOOD TRANSFUSION; HUMAN; KERNICTERUS; NEONATAL HYPERBILIRUBINEMIA; NEWBORN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; ADVERSE EFFECTS; BLOOD; DEVELOPING COUNTRY; HYPERBILIRUBINEMIA, NEONATAL; POVERTY; STANDARDS; UNNECESSARY PROCEDURE;

BILIRUBIN; DEVELOPING COUNTRIES; EXCHANGE TRANSFUSION, WHOLE BLOOD; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; KERNICTERUS; POVERTY; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; UNNECESSARY PROCEDURES;

EID: 84957429260     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000441324     Document Type: Review

References (54)

1. Diamond LK: Replacement transfusion as a treatment for erythroblastosis fetalis. Pediatrics 1948; 2: 520-524
2. National Institute for Health and Clinical Excellence: Neonatal jaundice: clinical guideline 98. 2010. http: //www.nice.org.uk/CG98 (accessed July 14, 2015)
3. Ip S, Chung M, Kulig J, O'Brien R, Sege R, Glicken S, Maisels MJ, Lau J; American Academy of Pediatrics Subcommittee on Hyperbilirubinemia: An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004; 114: e130-e153
4. Salas AA, Mazzi E: Exchange transfusion in infants with extreme hyperbilirubinemia: an experience from a developing country. Acta Paediatr 2008; 97: 754-758
5. Murki S, Kumar P: Blood exchange transfusion for infants with severe neonatal hyperbilirubinemia. Semin Perinatol 2011; 35: 175-184
6. Jackson JC: Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 1997; 99: E7
7. American Academy of Pediatrics: Management of hyperbilirubinaemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316
8. Steiner LA, Bizzarro MJ, Ehrenkranz RA, Gallagher PG: A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics 2007; 120: 27-32
9. Chitty HE, Ziegler N, Savoia H, Doyle LW, Fox LM: Neonatal exchange transfusions in the 21st century: a single hospital study. J Paediatr Child Health 2013; 49: 825-832
10. Owa JA, Ogunlesi TA: Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World J Pediatr 2009; 5: 51-55
11. Hameed NN, Na' Ma AM, Vilms R, Bhutani VK: Severe neonatal hyperbilirubinaemia and adverse short-term consequences in Baghdad, Iraq. Neonatology 2011; 100: 57-63
12. Rasul CH, Hasan MA, Yasmin F: Outcome of neonatal hyperbilirubinemia in a tertiary care hospital in Bangladesh. Malays J Med Sci 2010; 17: 40-44
13. Iskander I, Gamaleldin R, Kabbani M: Root causes for late presentation of severe neonatal hyperbilirubinaemia in Egypt. East Mediterr Health J 2012; 18: 882-887
14. Murray NA, Roberts IA: Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed 2004; 89: F101-F107
15. Canadian Paediatric Society: Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation). Paediatr Child Health 2007; 12: 1B-12B.
16. Bratlid D, Nakstad B, Hansen TW: National guidelines for treatment of jaundice in the newborn. Acta Paediatr 2011; 100: 499-505
17. Ebbesen F, Bjerre JV, Vandborg PK: Relation between serum bilirubin levels = 450 μmol/l and bilirubin encephalopathy; a Danish population-based study. Acta Paediatr 2012; 101: 384-389
18. Dijk PH, de Vries TW, de Beer JJ; Dutch Pediatric Association: Guideline 'Prevention, diagnosis and treatment of hyperbilirubinemia in the neonate with a gestational age of 35 or more weeks' (in Dutch). Ned Tijdschr Geneeskd 2009; 153: A93
19. Swiss Society of Neonatology: Assessment and treatment of jaundiced newborn infants 35 0/7 or more weeks of gestation. http://www.neonet.ch/assets/pdf/2006-Bili-Empfehlungen-e-final.pdf
20. Romagnoli C, Barone G, Pratesi S, Raimondi F, Capasso L, Zecca E, Dani C; Task Force for Hyperbilirubinaemia of the Italian Society of Neonatology: Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants = 35 weeks' gestational age. Ital J Pediatr 2014; 40: 11
21. Queensland Maternity and Neonatal Clinical Guidelines Program: Queensland Maternity and Neonatal Clinical Guideline: Neonatal Jaundice. 2012. http: //www.health.qld.gov. au/qcg/documents/g-jaundice.pdf
22. Auckland District Health Board: Newborn Services Clinical Guideline: Management of Neonatal Jaundice. 2012. http: //www.adhb. govt.nz/newborn/Guidelines/GI/Jaundice. htm
23. Kaplan M, Merlob P, Regev R: Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol 2008; 28: 389-397
24. Horn AR, Kirsten GF, Kroon SM, Henning PA, Möller G, Pieper C, et al: Phototherapy and exchange transfusion for neonatal hyperbilirubinaemia: neonatal academic hospitals'consensus guidelines for South African hospitals and primary care facilities. S Afr Med J 2006; 96: 819-24
25. National Neonatal Forum of India: Management of neonatal hyperbilirubinemia. http: //www.nnfpublication.org
26. Mishra S, Agarwal R, Deorari AK, Paul VK: Jaundice in the newborns. Indian J Pediatr 2008; 75: 157-163
27. Postgraduate Institute of Medical Education and Research: Jaundice; in Dutta S, Kumar P (eds): The PGI NICU Handbook of Protocols, ed 4. Chandigarh, The New Heart Trust, 2010
28. Ministry of Health of the Republic of Kenya: Basic Paediatric Protocols for Ages up to 5 Years. Nairobi, Ministry of Health of the Republic of Kenya, 2013, pp 40-42
29. Ministry of Health of Malaysia: Management of jaundice in healthy term newborns: Clinical practice guidelines. 2003. http: //www. acadmed.org.my/index.cfm?& menuid=67
30. World Health Organization: Pocket Book of Hospital Care for Children, ed 2: Guidelines for the Management of Common Childhood Illnesses. Geneva, WHO, 2013
31. Gamaleldin R, Iskander I, Seoud I, Aboraya H, Aravkin A, Sampson PD, Wennberg RP: Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics 2011; 128: e925-e931
32. Olusanya BO, Osibanjo FB, Mabogunje CA, Slusher TM, Olowe SA: The burden and management of neonatal jaundice in Nigeria: a scoping review of the literature. Niger J Clin Pract, in press
33. Mollison PL, Walker W: Controlled trials of the treatment of haemolytic disease of the newborn. Lancet 1952; 1: 429-433
34. Dijk PH, Hulzebos CV: An evidence-based view on hyperbilirubinaemia. Acta Paediatr Suppl 2012; 101: 3-10
35. Olusanya BO, Ogunlesi TA, Kumar P, Boo NY, Iskander IF, de Almeida MF, Vaucher YE, Slusher TM: Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings. BMC Pediatr 2015; 15: 39
36. De Luca D, Jackson GL, Tridente A, Carnielli VP, Engle WD: Transcutaneous bilirubin nomograms: a systematic review of population differences and analysis of bilirubin kinetics. Arch Pediatr Adolesc Med 2009; 163: 1054-1059
37. Coda Zabetta CD, Iskander IF, Greco C, Bellarosa C, Demarini S, Tiribelli C, Wennberg RP: Bilistick: a low-cost point-of-care system to measure total plasma bilirubin. Neonatology 2013; 103: 177-181
38. Watchko JF: Recent advances in the management of neonatal jaundice. Res Rep Neonatol 2014; 4: 183-193
39. Ahlfors CE: Predicting bilirubin neurotoxicity in jaundiced newborns. Curr Opin Pediatr 2010; 22: 129-133
40. Hulzebos CV, Dijk PH: Bilirubin-Albumin binding, bilirubin/albumin ratios, and free bilirubin levels: where do we stand?. Semin Perinatol 2014; 38: 412-421
41. Iskander I, Gamaleldin R, El Houchi S, El Shenawy A, Seoud I, El Gharbawi N, Abou-Youssef H, Aravkin A, Wennberg RP: Serum bilirubin and bilirubin/albumin ratio as predictors of bilirubin encephalopathy. Pediatrics 2014; 134: e1330-e1339
42. Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF: Hyperbilirubinemia in the newborn infant > or = 35 weeks' gestation: an update with clarifications. Pediatrics 2009; 124: 1193-1198
43. Olusanya BO, Emokpae AA, Zamora TG, Slusher TM: Addressing the burden of neonatal hyperbilirubinaemia in countries with significant glucose-6-phosphate dehydrogenase deficiency. Acta Paediatr 2014; 103: 1102-1109
44. Christensen RD, Yaish HM, Lemons RS: Neonatal hemolytic jaundice: morphologic features of erythrocytes that will help you diagnose the underlying condition. Neonatology 2014; 105: 243-249
45. Olusanya BO, Ogunlesi TA, Slusher TM: Why is kernicterus still a major cause of death and disability in low-income and middle-income countries?. Arch Dis Child 2014; 99: 1117-1121
46. Johnson L, Brown AK, Bhutani VK: BIND - a clinical score for bilirubin induced dysfunction in newborns. Pediatrics 1999; 104: 746-747
47. Radmacher PG, Groves FD, Owa JA, Ofovwe GE, Amuabunos EA, Olusanya BO, Slusher TM: Evaluating the severity of neonatal jaundice using a Modified bind score in a resource-constrained setting. BMC Pediatr 2015; 15: 28
48. Newman TB, Liljestrand P, Jeremy RJ, Ferriero DM, Wu YW, Hudes ES, Escobar GJ; Jaundice and Infant Feeding Study Team: Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 2006; 354: 1889-1900
49. Sgro M, Campbell D, Barozzino T, Shah V: Acute neurological findings in a national cohort of neonates with severe neonatal hyperbilirubinemia. J Perinatol 2011; 31: 392-396
50. Kuzniewicz MW, Wickremasinghe AC, Wu YW, McCulloch CE, Walsh EM, Wi S, Newman TB: Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics 2014; 134: 504-509
51. Kaplan M, Bromiker R, Hammerman C: Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium?. Neonatology 2011; 100: 354-362
52. Bhutani VK, Johnson L: The jaundiced newborn in the emergency department: prevention of kernicterus. Clin Ped Emerg Med 2008; 9: 149-159
53. Edris AA, Ghany EA, Razek AR, Zahran AM: The role of intensive phototherapy in decreasing the need for exchange transfusion in neonatal jaundice. J Pak Med Assoc 2014; 64: 5-8
54. Slusher TM, Olusanya BO, Vreman HJ, Brearly AM, Vaucher YE, Lund TC, Wong RJ, Emokpae AA, Stevenson DK: A randomized trial of filtered sunlight phototherapy in African neonates. New Engl J Med 2015; 373: 1115-1124